| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AMGEN INC | EVP, R&D, & Chief Sci. Officer | Common Stock | 29,753 | $9,269,547 | $311.55 | 06 May 2025 | Direct |
| AMGEN INC | EVP, R&D, & Chief Sci. Officer | Nqso (Right to Buy) | 22,944 | $6,204,975 | $270.44 | 06 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AMGN | AMGEN INC | 06 May 2025 | 2 | $6,204,975 | 4 | EVP, R&D, & Chief Sci. Officer | 08 May 2025, 20:49 |
| AMGN | AMGEN INC | 07 May 2024 | 2 | $5,586,480 | 4 | EVP, R&D, & Chief Sci. Officer | 09 May 2024, 18:59 |
| AMGN | AMGEN INC | 09 Feb 2024 | 2 | $0 | 4 | EVP, R&D, & Chief Sci. Officer | 12 Feb 2024, 19:50 |
| AMGN | AMGEN INC | 18 Dec 2023 | 0 | $0 | 3 | EVP, R&D, & Chief Sci. Officer | 19 Dec 2023, 20:38 |